Tocilizumab Increases Body Weight and Serum Adipokine Levels in Patients with Rheumatoid Arthritis Independently of Their Treatment Response: a Retrospective Cohort Study.

CONCLUSION: Weight and the leptin-adiponectin ratio increased after tocilizumab treatment. Given that cardiovascular (CV) risk factors may deteriorate in patients with RA who receive tocilizumab, further studies are required to determine the effects of weight gain on CV outcomes in these patients.
PMID: 32508063 [PubMed - in process]

Source: J Korean Med Sci - June 7, 2020 Category: General Medicine Authors: Choi IA, Sagawa A, Lee EY, Lee EB, Song YW Tags: J Korean Med Sci Source Type: research